1-2 of 2
Christopher A. Maher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases

Free
Gregory C. Fox, Xinming Su, Jennifer L. Davis, Yalin Xu, Kristin A. Kwakwa, Michael H. Ross, Francesca Fontana, Jingyu Xiang, Alison K. Esser, Elizabeth Cordell, Kristen Pagliai, Ha X. Dang, Jothilingam Sivapackiam, Sheila A. Stewart, Christopher A. Maher, Suzanne J. Bakewell, James A.J. Fitzpatrick, Vijay Sharma, Samuel Achilefu, Deborah J. Veis, Gregory M. Lanza, Katherine N. Weilbaecher
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (6): 1183–1198.
https://doi.org/10.1158/1535-7163.MCT-20-0931
Published: 01 June 2021
View article titled, Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases
Open the PDF for Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases in another window
Includes: Supplementary data
Journal Articles

Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase, an Exploitable Tumor Target

Free
Colin C. Collins, Stanislav V. Volik, Anna V. Lapuk, Yuwei Wang, Peter W. Gout, Chunxiao Wu, Hui Xue, Hongwei Cheng, Anne Haegert, Robert H. Bell, Sonal Brahmbhatt, Shawn Anderson, Ladan Fazli, Antonio Hurtado-Coll, Mark A. Rubin, Francesca Demichelis, Himisha Beltran, Martin Hirst, Marco Marra, Christopher A. Maher, Arul M. Chinnaiyan, Martin Gleave, Joseph R. Bertino, Martin Lubin, Yuzhuo Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (3): 775–783.
https://doi.org/10.1158/1535-7163.MCT-11-0826
Published: 06 March 2012
View article titled, Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase, an Exploitable Tumor Target
Open the PDF for Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase, an Exploitable Tumor Target in another window
Includes: Supplementary data